255 An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRis) in combination with conventional radiotherapy in NSCLC

Walls, G., Horne, A., Franks, K. et al. (23 more authors) (2025) 255 An update on the CONCORDE study: a phase Ib platform study of DNA damage repair inhibitors (DDRis) in combination with conventional radiotherapy in NSCLC. In: Lung Cancer. 23rd BTOG Annual Conference 2025, 03-05 Mar 2025, Belfast, Northern Ireland. Elsevier BV , p. 108364.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Walls, G.
  • Horne, A.
  • Franks, K.
  • Harrow, S.
  • Shaw, P.
  • Hiley, C.
  • Hatton, M. ORCID logo https://orcid.org/0000-0003-2778-7926
  • Forster, M.
  • Jones, R.
  • Yang, H.
  • Conibear, J.
  • Rudd, P.
  • McAleese, J.
  • Rizos, K.
  • Ojo, O.
  • Stavraka, C.
  • Hassani, A.
  • Norris, M.
  • Phillip, R.
  • Walker, F.
  • Kendall, J.
  • Oughton, J.
  • Chalmers, A.
  • Brown, S.
  • Greystoke, A.
  • Faivre-Finn, C.
Copyright, Publisher and Additional Information:

© 2025 Elsevier Inc.
Keywords: Biomedical and Clinical Sciences; Clinical Sciences; Lung; Health Disparities; Radiation Oncology; Genetics; Minority Health; Cancer; Radiotherapy and other non-invasive therapies; Radiotherapy and other non-invasive therapies; Cancer
Dates:
  • Published (online): February 2025
  • Published: February 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jul 2025 09:59
Last Modified: 11 Jul 2025 09:59
Status: Published
Publisher: Elsevier BV
Identification Number: 10.1016/j.lungcan.2025.108364
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)